Vaxcyte

Vice President, U.S. Market Access & Pricing

Vaxcyte$333K — $388K *
Pharmaceuticals & Biotech
11 - 15 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree required; advanced degree (MBA, MPH, PharmD, PhD) preferred
  • 15+ years in market access, pricing, reimbursement, or related biotech/pharma functions
  • Experience leading product launches, preferably in vaccines or buy-and-bill products
  • Deep understanding of adult vaccine access dynamics and various reimbursement models
  • Experience in lean or pre-commercial biotech environments, building market access capabilities from scratch
  • Strong cross-functional leadership and stakeholder influence skills
  • Proven ability to manage gross-to-net financial modeling and payer strategies

Responsibilities

  • Lead U.S. market access strategy for the adult pneumococcal vaccine, focusing on pricing and reimbursement
  • Develop launch readiness plans aligning with regulatory and immunization milestones
  • Shape access strategies across various payer and public health channels
  • Drive engagement strategies for key stakeholders including GPOs and public health entities
  • Establish pricing strategy and gross-to-net assumptions based on market dynamics
  • Ensure coding, coverage, reimbursement, and provider economics readiness
  • Partner with Medical Affairs to deliver HEOR and value evidence for payer decisions
  • Build and lead an efficient market access function using external partners

Benefits

  • Hybrid work arrangement with flexibility (minimum of 2-3 days in-office)
  • Relocation assistance available
  • Comprehensive benefits package
  • Equity component included in the compensation package
Full Job Description
Summary:

The Vice President, Market Access will lead the strategy and execution of all market access activities to support the successful launch of the company's adult pneumococcal vaccine. Reporting to the Chief Commercial Officer, this role will be accountable for ensuring broad, timely, and sustainable access across public and private channels.

As Vaxcyte prepares for its first commercial launch, the VP will operate as a hands-on leader, building foundational capabilities while directly shaping payer, provider, and policy environments. This role requires a balance of strategic leadership and execution, with a particular focus on navigating the unique access dynamics of adult vaccines, including public health recommendations, buy-and-bill reimbursement, and site-of-care considerations.
Essential Functions:
  • Lead development and execution of the U.S. market access strategy for the adult pneumococcal vaccine, including pricing, reimbursement, contracting, and channel strategy
  • Define and drive launch readiness plans aligned to regulatory approval and immunization guideline milestones (e.g., ACIP or other recommending bodies)
  • Shape access strategies across commercial payers, Medicare, Medicaid, and public health channels
  • Develop and execute engagement strategies for key stakeholders, including GPOs, IDNs, retail pharmacy, and public health entities
  • Establish pricing strategy and gross-to-net assumptions, ensuring alignment with vaccine-specific market dynamics
  • Ensure readiness for coding, coverage, reimbursement, and provider economics within buy-and-bill and pharmacy settings
  • Partner with Medical Affairs to define and deliver HEOR and value evidence to support payer and policy decision-making
  • Serve as the market access lead across cross-functional teams, aligning with Commercial, Medical, Regulatory, Government Affairs, and Finance
  • Build and lead a lean market access function, leveraging external partners to scale capabilities efficiently
  • Working cross functionally, prepare for CDC immunization program, state immunization program, and ACIP-adjacent policy stakeholder engagements; translate ACIP recommendation language into access and coverage implications across all channels
  • Develop and execute integrated PBM, commercial payer, and Medicare Part B and D contracting strategies to ensure optimal formulary positioning, coverage, and patient access across channels.
  • Support development of national retail pharmacy and alternate vaccination site strategies, establishing partnerships that maximize vaccine availability, administration, and uptake.
  • Develop scenario-based access, reimbursement, and customer adoption strategies aligned to potential ACIP recommendation outcomes and evolving adult immunization guidelines
Requirements:
  • Bachelor's degree required; advanced degree (MBA, MPH, PharmD, PhD) preferred
  • 15+ years of experience in market access, pricing, reimbursement, or related functions within biotech/pharma
  • Demonstrated experience supporting or leading product launches, ideally in vaccines, infectious disease, or buy-and-bill products
  • Strong understanding of adult vaccine access dynamics, including public health recommendations, Medicare Part B and Part D reimbursement, Medicaid, 340B program implications, CDC contract vehicles (Section 317 and VFC), and site-of-care economics
  • Experience operating in lean or pre-commercial biotech environments, with a demonstrated track record of building market access capabilities from the ground up
  • Proven ability to balance strategic thinking with hands-on execution
  • Strong cross-functional leadership and stakeholder influence skills
  • Experience managing gross-to-net financial modelling, including rebate strategy across payers
  • Demonstrated ability to work collaboratively with HEOR teams to translate cost-effectiveness models, budget impact analyses, and payer value dossiers into P&T committee submissions or ICER reviews
  • Prior engagement with CDC immunization programs, state immunization programs, or ACIP-adjacent policy processes; understanding of how ACIP recommendation language drives uptake across channels

Reports to: Chief Commercial Officer

Location: East Coast - US

Work Arrangement: Hybrid (minimum of 2-3 days per week) / Remote

Compensation:

The compensation package will be competitive and includes comprehensive benefits and an equity component.

Salary Range: $333,000 - $388,000 (SF Bay Area). Salary ranges for non-California locations may vary.

Relocation:

This role is eligible for relocation assistance.

About Vaxcyte

Vaxcyte is a clinical-stage biotechnology company developing a new generation of vaccines to address some of the most important and deadly infectious diseases worldwide. The company's cell-free protein synthesis platform, comprising the XpressCFTM platform, is capable of rapidly generating protein antigens that can be used in vaccines to protect against bacterial and viral pathogens. Vaxcyte's lead vaccine candidate, VAX-24, is a preclinical, 24-valent pneumococcal conjugate vaccine (PCV) being developed for the prevention of pneumococcal disease. The company is also developing VAX-XP, a PCV with expanded serotype coverage, as well as vaccines for Group A Streptococcus, Group B Streptococcus, and Lyme disease.
Learn more about Vaxcyte
Size
89 employees
Market Cap
$3.6 billion
Industry
Founded
2013
NASDAQ

More Jobs at Vaxcyte

More Pharmaceuticals & Biotech Jobs

Find similar Vice President, U.S. Market Access & Pricing jobs: